Pasternak and Standifer reply

Trends in Pharmacological Sciences

Volumn 17, Issue 6, 1996, Pages 217-218

  Pasternak, Gavril W ^a   Standifer, Kelly M ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; KAPPA 3 OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANALGESIA; CLASSIFICATION; LETTER; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING;

EID: 0029941374     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-6147(96)81602-6     Document Type: Letter

References (13)

1. Pan, Y. X., Cheng, J., Xu, J. and Pasternak, G. W. (1994) Regul. Peptides 54, 217-218
2. Pan, Y. X. et al. (1995) Mol. Pharmacol. 47, 1180-1188
3. Uhl, G. R., Childers, S. and Pasternak, G. W. (1994) Trends Neurosci. 17, 89-93
4. Pan, Y. X., Xu, J. and Pasternak, G. W. Gene (in press)
5. Pasternak, G. W. and Standifer, K. M. (1995) Trends Pharmacol. Sci. 16, 344-350
6. Wang, J. B. et al. (1994) FEBS Lett. 348, 75-79
7. Mollereau, C. et al. (1994) FEBS Lett. 341, 33-38
8. Wick, M. J., Minnerath, S. R., Roy, S., Ramakrishnan, S. and Loh, H. H. (1995) Mol. Brain Res. 32, 342-347
9. Halford, W. P., Gebhardt, B. M. and Carr, D. J. J. (1995) J. Neuroimmunol. 59, 91-101
10. Reinscheid, R. K. et al (1995) Science 270, 792-794
11. Meunier, J. C. et al. (1995) Nature 377, 532-535
12. Cheng, J., Standifer, K. M., Tublin, P. R., Su, W. and Pasternak, G. W. (1995) J. Neurochem. 65, 170-175
13. Standifer, K. M. et al. (1994) J. Pharmacol. Exp. Ther. 270, 1246-1255